Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients
The aim of this study was to investigate the clinical significance of serum homocysteine (Hcy) as a biomarker for early diagnosis of diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM) patients.
Guardado en:
Autores principales: | Ye Bin, Zhu Xiangying, Zeng Zhifu, Ji Xiaozhen, Ji Meixia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31088bfdb50247fdadc12c35fa20b084 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of coagulation and inflammation in the development of diabetic nephropathy in patients withdiabetes mellitus type 2
por: Yulia Valer'evna Khasanova, et al.
Publicado: (2012) -
Homocysteine is potential serological marker for predicting the risk of deep venous thrombosis of the lower extremities in patients received operation of lower limb fracture
por: Chen Xiao, et al.
Publicado: (2021) -
New insights on microRNAs in diabetic nephropathy: potential biomarkers for diagnosis and therapeutic targets
por: Elena Sergeevna Kamyshova, et al.
Publicado: (2017) -
Diabetic nephropathy and myocardial lesions in children with type 1 diabetes mellitus
por: Larisa Vasil'evna Kazakova, et al.
Publicado: (2009) -
Microchip Immunoassays for Monitoring Renal Function: Rapid, Low-Cost, and Highly Sensitive Quantification of Urinary Biomarkers of Diabetic Nephropathy
por: Toshihiro Kasama, et al.
Publicado: (2021)